Receive our newsletter – data, insights and analysis delivered to you
  1. News
April 9, 2020

Regulatory delays imminent due to the coronavirus outbreak: Poll

The likelihood of regulatory delays as a consequence of the coronavirus outbreak is high, according to a recent poll conducted by Verdict.

The likelihood of regulatory delays as a consequence of the coronavirus outbreak is high, according to a recent poll conducted by Verdict.

A majority 62% of the poll respondents said that the delays are very likely, while 19% opined that the delays are ‘somewhat likely’.

Delays are unlikely, according to just 19% of the respondents.

The analysis is based on 679 responses received during the poll period from 26 March to 02 April.

Regulatory delays-coronavirus outbreak

The coronavirus outbreak is also expected to cause clinical trial delays, according to another poll run by Verdict during the same period.

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide
Why Asia-Pacific is the next frontier for decentralized clinical trials

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU